CYP2C19*17 May Increase the Risk of Death Among Patients with an Acute Coronary Syndrome and Non-Valvular Atrial Fibrillation Who Receive Clopidogrel and Rivaroxaban

Overview of attention for article published in Pharmacogenomics and Personalized Medicine, January 2020

Altmetric Badge

Mentioned by

twitter: 1 X user

Citations

dimensions_citation: 14 Dimensions

Readers on

mendeley: 42 Mendeley

Summary X Dimensions citations

So far, Altmetric has seen 1 X post from an account with 29,570 followers.

CYP2C19*17 May Increase the Risk of Death Among Patients with an Acute Coronary Syndrome and Non-Valvular Atrial Fibrillation Who Receive Clopidogrel and Rivaroxaban https://t.co/piWP7oJjHY

22 Jan 2020

Reply Repost Favourite

Dove Medical Press

Article Metrics

CYP2C19*17 May Increase the Risk of Death Among Patients with an Acute Coronary Syndrome and Non-Valvular Atrial Fibrillation Who Receive Clopidogrel and Rivaroxaban

Mentioned by

Citations

Readers on